This 13th Annual Board Review and Comprehensive Update in Hematology and Medical Oncology offers an in-depth and current review of the diagnosis, staging,and management of neoplastic diseases,encompassing both solid tumors and hematologic malignancies. Expert-led lectures and discussions cover disease-specific topics across gastrointestinal, gynecologic, thoracic, ead and neck, genitourinary, soft tissue and skin, and central nervous system cancers, as well as hematologic malignancies. This program is designed to support participants in their preparation for the American Board of Internal Medicine (ABIM) certification and recertification examinations in Hematology and Medical Oncology and is now avaible on Medustudy website

Videos+PDFs

topcs

Solid Tumors
COLON CANCER Leonard Saltz, MD
Executive Director for Clinical Value & Sustainability;
Head, Colorectal Oncology Section;
Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical Center
MELANOMA Michael A. Postow, MD
Chief, Melanoma Service;
Co-Director, Melanoma Disease Management Team
Memorial Sloan Kettering Cancer Center
KIDNEY CANCER Robert J. Motzer, MD
Section Head, Kidney Cancer;
Jack and Dorothy Byrne Chair in Clinical Oncology;
Attending Physician, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
PROSTATE CANCER Susan F. Slovin, MD, PhD
Associate Vice Chair, Academic Affairs,
Department of Medicine;
Attending Physician, Genitourinary Oncology Service
& Cellular Therapy Service
Memorial Sloan Kettering Cancer Center
MESOTHELIOMA Michael D. Offin, MD
Co-Director, Mesothelioma Program;
Assistant Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
UROTHELIAL CANCER Gopa Iyer, MD
Section Head, Bladder Cancer;
Associate Attending Physician, Genitourinary Oncology Service
& Early Drug Development Service
Memorial Sloan Kettering Cancer Center
TESTIS CANCER Darren R. Feldman, MD
Chair, Quality Assurance;
Section Head, Germ Cell Cancer;
Associate Attending Physician, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medical College
UTERINE, CERVIX, AND
OTHER GYNECOLOGIC
CANCERS
Carol Aghajanian, MD
Chief, Gynecologic Medical Oncology Service;
Avon Chair in Gynecologic Oncology Research
Memorial Sloan Kettering Cancer Center
OVARIAN CANCER Rachel N. Grisham, MD
Section Head, Ovarian Cancer;
Director, Gynecologic Medical Oncology, MSK Westchester;
Associate Attending Physician,
Gynecologic Medical Oncology Service
Memorial Sloan Kettering Cancer Center
BREAST CANCER
SURGERY
Anita Mamtani, MD, FACS
Surgical Site Director, MSK Bergen;
Assistant Attending Surgeon, Breast Service
Memorial Sloan Kettering Cancer Center
BREAST CANCER
RADIATION THERAPY
Lior Z. Braunstein, MD
Associate Attending Radiation Oncologist,
External Beam Radiotherapy Service
Memorial Sloan Kettering Cancer Center
HEREDITARY CANCER
GENETICS
Zsofia K. Stadler, MD
Clinical Director, Clinical Genetics Service;
Associate Attending Physician, Clinical Genetics Service
& Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
SMALL CELL LUNG
CANCER
Alissa J. Cooper, MD
Assistant Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
HER2-POSITIVE
BREAST CANCER
Joshua Z. Drago, MD, MS
Assistant Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
TRIPLE-NEGATIVE
BREAST CANCER
Rachel Sanford, MD
Associate Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
HORMONE RECEPTOR-POSITIVE BREAST
CANCER
Devika Gajria, MD
Medical Site Director, MSK Bergen;
Assistant Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
CARCINOMA OF
UNKNOWN PRIMARY
Anna M. Varghese, MD
Associate Attending Physician,
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
HEPATOCELLULAR
CANCER AND
CHOLANGIOCARCINOMA
Ghassan K. Abou-Alfa, MD, JD, MBA
Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor, Weill Cornell College at Cornell University
Adjunct Professor of Medical Diplomacy, Trinity College Dublin
PANCREATIC AND
NEUROENDOCRINE
CANCERS
Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology;
Chair, Human Research Protection Program and
Institutional Review Board;
Co-Director, Medical Initiatives,
David M. Rubenstein Center for Pancreatic Cancer Research;
Section Head, Hepatopancreaticobi;
Attending Physician, Member,
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
NON-SMALL CELL
LUNG CANCER
Gregory J. Riely, MD, PhD
Ning Zhao and Ge Li Chair in Lung Cancer Research;
Vice Chair, Clinical Research;
Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
HEAD AND NECK,
THYROID, AND
NON-MELANOMA SKIN
CANCERS
Lara A. Dunn, MD
Assistant Attending Physician,
Head and Neck Oncology Service
Memorial Sloan Kettering Cancer Center
ANAL AND RECTAL
CANCERS
Andrea Cercek, MD
Section Head, Colorectal Cancer;
Co-Director, Center for Young Onset Colorectal
and Gastrointestinal Cancers;
Associate Attending Physician,
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
ESOPHAGEAL AND
GASTRIC CANCERS
David H. Ilson, MD, PhD, FACP, FASCO
Attending Physician, Member,
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
CENTRAL NERVOUS
SYSTEM TUMORS
Thomas J. Kaley, MD
Chief, Neuro-Oncology and Cancer Neurology Service;
Vice Chair for Clinical Research, Department of Neurology;
Chair, Institutional Review Board (IRB-C);
Associate Attending Neuro-Oncologist
Memorial Sloan Kettering Cancer Center
SARCOMA Robert Maki, MD, PhD
Attending Physician, Member,Sarcoma Medical Oncology
Service & Early Drug Development Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
INFECTIOUS DISEASE Susan K. Seo, MD
Director, Antibiotic Management Program;
Attending Physician, Infectious Disease Service
Memorial Sloan Kettering Cancer Center
Professor of Clinical Medicine, Weill Cornell Medical College
Pharmacology
PHARMACOLOGY I & II Mrinal M. Gounder, MD
Physician Ambassador, India and Asia;
Associate Attending Physician, Sarcoma Medical Oncology
Service & Early Drug Development Service
Memorial Sloan Kettering Cancer Center
Malignant Hematology
ACUTE MYELOID
LEUKEMIA
Eytan M. Stein, MD
Chief, Leukemia Service;
Director, Program for Drug Development in Leukemia,
Division of Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
LOW-GRADE
NON-HODGKIN
LYMPHOMA
Andrew D. Zelenetz, MD, PhD
Medical Director, Quality Informatics;
Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center
CHRONIC LYMPHOCYTIC
LEUKEMIA /
SMALL LYMPHOCYTIC
LYMPHOMA
Meghan C. Thompson, MD
Assistant Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center
DIFFUSE LARGE B-CELL
LYMPHOMA /
MANTLE CELL LYMPHOMA
/ BURKITT LYMPHOMA
Paul A. Hamlin, MD
Medical Director, David H. Koch Center for Cancer Care;
Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center
Professor of Clinical Medicine, Weill Cornell Medical College
HODGKIN LYMPHOMA /
T CELL
Alison J. Moskowitz, MD
Associate Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center
AUTO / ALLO Gunjan L. Shah, MD
Assistant Attending Physician, Bone Marrow Transplant
Service & Cellular Therapy Service
Memorial Sloan Kettering Cancer Center
CAR T CELLS Craig Sauter, MD
Director, Blood and Marrow Transplant Program
Cleveland Clinic
ACUTE LYMPHOCYTIC
LEUKEMIA
Mark B. Geyer, MD
Adolescent and Young Adult Program Leader;
Adult Lymphoblastic Leukemia Program Leader;
Assistant Attending Physician, Leukemia Service;
Chair, Quality Assessment, Cellular Therapy Service
Memorial Sloan Kettering Cancer Center
MYELOPROLIFERATIVE
NEOPLASMS
Raajit K. Rampal, MD, PhD
Director, Center for Hematologic Malignancies;
Director, Myeloproliferative Neoplasms Program;
Associate Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center
MYELODYSPLASTIC Aaron D. Goldberg, MD, PhD
Assistant Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center
CHRONIC MYELOGENOUS
LEUKEMIA
Michael J. Mauro, MD
Attending Physician, Member, Leukemia Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
MYELOMA / AMYLOID Malin Hultcrantz, MD, PhD
Assistant Attending Physician, Myeloma Service
Memorial Sloan Kettering Cancer Center
Assistant Professor of Medicine, Weill Cornell Medicine
Benign Blood Disorders
APPROACH TO THE
BLEEDING PATIENT
Avi Leader, MD
Assistant Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center
THROMBOTIC
DISORDERS
Jeffrey Zwicker, MD
Chief, Hematology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
ANTITHROMBOTIC AND
ANTIPLATELET THERAPY
Simon Mantha, MD, MPH
Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center
THROMBOCYTOPENIA
AND ITP
Cy R. Wilkins, MD
Assistant Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center
Assistant Professor of Clinical Medicine,
Weill Cornell Medical College
SICKLE CELL DISEASE,
THALASSEMIA
Susanna Curtis, MD, PhD
Assistant Professor of Medicine,
Hematology and Medical Oncology;
Assistant Director, The Mount Sinai Comprehensive
Sickle Cell Program
Icahn School of Medicine at Mount Sinai
HEMOLYTIC ANEMIA Gerald A. Soff, MD
Chief, Classical Hematology Service
University of Miami Health System/
Sylvester Comprehensive Cancer Center
Soffer Clinical Research Building
CLINICAL INDICATIONS
FOR USE OF BLOOD
PRODUCTS AND
ASSOCIATED RISKS
P. Dayand Borge, MD, PhD
Chief, Transfusion Medicine and Cell Therapy Service
Memorial Sloan Kettering Cancer Center
TRANSFUSION

REACTIONS